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Streptococcus agalactiae (Group B Streptococcus, GBS) is the leading cause of life-threat-
ening meningitis in human newborns in industrialized countries. Meningitis results from neo-
natal infection that occurs when GBS leaves the bloodstream (bacteremia), crosses the
blood-brain barrier (BBB), and enters the central nervous system (CNS), where the bacteria
contact the meninges. Although GBS is known to invade the BBB, subsequent interaction
with astrocytes that physically associate with brain endothelium has not been well studied.
Methodology/Principal Findings
We hypothesize that human astrocytes play a unique role in GBS infection and contribute to
the development of meningitis. To address this, we used a well- characterized human fetal
astrocyte cell line, SVG-A, and examined GBS infection in vitro. We observed that all GBS
strains of representative clinically dominant serotypes (Ia, Ib, III, and V) were able to adhere
to and invade astrocytes. Cellular invasion was dependent on host actin cytoskeleton rear-
rangements, and was specific to GBS as Streptococcus gordonii failed to enter astrocytes.
Analysis of isogenic mutant GBS strains deficient in various cell surface organelles showed
that anchored LTA, serine-rich repeat protein (Srr1) and fibronectin binding (SfbA) proteins
all contribute to host cell internalization. Wild-type GBS also displayed an ability to persist
and survive within an intracellular compartment for at least 12 h following invasion. More-
over, GBS infection resulted in increased astrocyte transcription of interleukin (IL)-1β, IL-6
and VEGF.
Conclusions/Significance
This study has further characterized the interaction of GBS with human astrocytes, and has
identified the importance of specific virulence factors in these interactions. Understanding
the role of astrocytes during GBS infection will provide important information regarding BBB
disruption and the development of neonatal meningitis.
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Introduction
Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is the leading cause of
neonatal meningitis. Meningitis is defined by an inflammation of the protective membranes
covering the brain and spinal cord, known collectively as the meninges. Rates of GBS meningi-
tis in neonates have been estimated in the US and in the UK to be 0.65 and 0.72 per 1000 live
births respectively [1, 2]. Despite chemotherapeutic intervention, infection can result in high
mortality with just under half of surviving infants suffering permanent neurological damage,
including cognitive deficits, blindness, hearing loss, seizures and spastic quadriplegia (Cerebral
Palsy), [3–6]. Nine different GBS serotypes (Ia, Ib, II-VIII) have been identified and are
grouped based on antigenic differences in the structure of the capsule polysaccharide [7].
Three of the nine GBS capsular serotypes (Ia, III and V) have been linked to a majority of neo-
natal GBS related meningitis [8]. Other GBS virulence factors have been shown to contribute
to experimental meningitis including the β-hemolysin/cytolysin (β-h/c) [9], iagA, which is re-
quired for proper anchoring of lipoteichoic acid (LTA) to the cell wall [10], HvgA [11] and sur-
face proteins that promote interaction with extracellular matrix components such as serine
rich repeat protein, Srr1 [12, 13], streptocococcal fibronectin binding protein, SfbA [14], and
the pilus tip adhesin, PilA [15].
The development of neonatal GBS disease begins when the bacteria successfully colonize
the vaginal epithelium of a pregnant mother. This involved multiple steps before and after
birth, which includes bacterial penetration of the placental membranes or inhalation of infected
fluids containing GBS. Bacterial meningitis occurs when GBS leaves the bloodstream, breaches
the endothelial blood-brain barrier (BBB) and replicates within cerebral spinal fluid (CSF),
provoking an overwhelming host inflammatory response [16]. The BBB is primarily composed
of a single layer of specialized brain microvascular endothelial cells (BMEC), and together with
astrocytes, pericytes, neurons and the extracellular matrix, constitute the neurovascular unit
(NVU)[17]. The BBB functions to protect the brain from circulating toxins and microbial in-
fection by maintaining extremely tight intercellular junctions that comprise gap, adherens,
and/or desmosomal junctions that link cells together and prohibit pinocytosis [18, 19]. GBS
penetration of the BBB involves a complex interplay between the GBS cell surface components
and the endothelial cells of the BBB, however, the mechanism(s) by which GBS crosses the
BBB and engages the NVU are not well understood. Astrocytes encircle BMEC with their pseu-
dopodia and maintain direct contact with cerebrospinal capillaries. Several studies indicate
that astrocytes up-regulate and maintain BBB functions [20–22] and are predicted to have an
essential role in protection against invasion by GBS and other microbes [22, 23]. Many studies
use human BMEC (hBMEC) as an in vitromodel to examine how GBS interactions enable en-
dothelial penetration [3, 9, 10, 24]. However, while one study has demonstrated that GBS inter-
acts directly with human fetal astrocytes [25], the nature of these interactions have not been
thoroughly investigated. We hypothesize that astrocytes play a unique role in GBS infection
and the development of meningitis. In the current study, we examined the capacity of GBS to
attach, invade, survive intracellularly, and induce cytokine transcription in a human astrocyte
cell line. We further identify GBS surface expressed factors that contribute to
these interactions.
Materials and Methods
Bacterial strains and growth condition
The following wild-type clinical strains of Streptococcus agalactiae GBS were used in this study:
COH1 (ATCC BAA 1176), NCTC 10/84 (ATCC 49447), A909 (ATCC 1138), H36B (ATCC
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BAA 1174), NEM 316 (ATCC 12403), 515 [26]. The following mutant strains of COH1 and
NCTC 10/84 were previously generated as described: ΔcylE [27], Δiag [10], HY106 [28] [9],
ΔpilA and ΔpilB [18], Δsrr1 [12], and ΔsfbA [14]. The COH1 strain expressing GFP,
COH1-GFP, was generated as described [14]. The streptococcal species Streptococcus gordonii
M99 strain [29] was used as a control. All bacteria were grown in Todd-Hewitt broth (THB)
(Hardy Diagnostics, Santa Maria, CA) at 37°C and to early to mid log-phase, equivalent to an
optical density of 0.4 measured at 600 nm wavelength which represents ~1 x 108 CFU (Colony
Forming Unit)/ml. For antibiotic selection, 2 μg / mL chloramphenicol (Sigma) and 5 μg / mL
erythromycin (Sigma) was incorporated in the growth medium when required.
Cell culture
The human astrocyte cell line, SVG-A was generously provided by Dr. Walter J. Atwood
(Brown University, Providence, RI). SVG-A cells were derived from human fetal glial cells
transformed with an origin-defective simian virus 40 (SV40) mutant [30]. Cells were grown in
DMEM/F12 medium (DMEM/Ham’s F12 50/50) (Mediatech Inc., Manassas, VA.) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS) and 100X penicillin-streptomycin
antibiotic (0.003 units of penicillin and 0.01mg streptomycin/ml) at 37°C and 5% CO2. Prior to
bacterial infection SVG-A cells were seeded on 24-well plates coated with 1% rat-tail collagen
(Fisher Scientific, Pittsburgh, PA) until they reached 90–100% confluency before bacteria
were added.
Bacterial infection assays
GBS adherence, invasion, and intracellular survival assays of SVG-A were conducted as de-
scribed previously [3]. Briefly, cells were grown to confluency in 24-well tissue culture plates
and washed prior to bacterial infection. Bacteria were grown to mid-log phase and added at a
multiplicity of infection (MOI) of 0.1, 1 or 10 as indicated for adherence, invasion, and intracel-
lular survival assays. For adherence assays, after 2 hours of incubation, cells were washed 6
times with PBS. Cells were removed from plates by adding 0.025% trypsin-EDTA and then
lysed with 0.025% Triton X-100. Lysate was serially diluted and plated on THB agar plates to
quantify adherent colony forming units (CFU). Total adherent CFU was calculated as (total
CFU recovered/total CFU of original inoculum)×100%. The original inoculum was ~ 1 X 105
CFU. To quantify invading bacteria, cells were incubated with GBS for 2 hours, monolayers
washed 3 times with PBS, treated with media containing antibiotics, and incubated for an addi-
tional 2 hours for invasion assays, or as given for survival assays. Cells were washed 3 times
with PBS, lysed as described above, and viable intracellular GBS determined by serial dilution
plating as quantified above.
In indicated experiments the actin polymerization inhibitor cytochalasin D was used to ana-
lyze the mechanism of GBS invasion of SVG-A cells. Cytochalasin D (Sigma-Aldrich, St. Louis,
MO) was reconstituted at a concentration of 5 mg/ml in DMSO and cells were pretreated with
1, 2, or 5 μg/ml cytochalasin D or DMSO vehicle control for 30 min at 37°C and 5% CO2 prior
to addition of GBS. Intracellular CFU was recovered and assessed as described above. Strepto-
coccus gordonii, a bacterium not associated with CNS disease, was used as a control at an MOI
of 1, to assess adherence and invasion compared to clinically relevant GBS isolates.
Fluorescence Microscopy
To ensure that SVG-A cells represent a homogenous population of astrocytes, cells were
stained with APC mouse anti-human CD44, Pgp-1 Ly24 (PharMingen-A Becton Dickinson
Co., San Jose, CA) and anti- glial fibrillary acidic protein (GFAP) antibody (Abcam Inc.,
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Cambridge, MA) in 1X PBS at a 1:1000 dilution. DAPI (Vector Laboratories, Burlingame, CA)
was used to stain the nucleus. Cells were then fixed with the 4% paraformaldehyde, immunos-
tained and then visualized. To visualize GBS cellular invasion SVG-A cells were grown on col-
lagen-coated glass cover slips to confluence, GBS expressing green fluorescent protein (GFP),
COH1-GFP, bacteria were added at an MOI of 10 or 50 and incubated for various times at
37°C. Cell Mask deep red plasma membrane stain (Life Technologies, Grand Island, NY) ac-
cording to the manufacturers protocol and DAPI nuclear stain were used to visualize intracel-
lular GBS. After processing, coverslips were mounted using Cytoseal-60 (Thermo Scientific,
Waltham, MA). Images and Z-stacks were captured using a Zeiss Axio Observer.Z1 inverted
microscope using Plan-Apo 63x oil objective equipped with an AxiocamMRm camera device.
Axiovision 4.0 software was used to generate images.
Transmission electron microscopy
SVG-A cells were grown in 24-well plates coated with collagen to confluence, and GBS was
subsequently added to monolayers as described above. Following incubation, monolayers were
washed with 1 X PBS and collected by centrifugation. Pellets were fixed in 2% gluteraldehyde,
4% formaldehyde in 0.1 M cacodylate buffer at pH 7.4 for 2 h at room temperature. Pellets
were then fixed again in 1% osmium tetroxide (OsO4) in 0.1M cacodylate buffer for 1 h. After
rinsing with water, samples were dehydrated with increasing series of concentrations of ethanol
and left on a rotator overnight in a 50% solution of Spurr resin and acetone. The next day sam-
ples were placed in 100% Spurr and placed on a rotator for several hours before placing in fresh
100% Spurr again and polymerized in oven for 24h at 60° C. The sample blocks were sectioned
at 50 nm on a Leica ultramicrotome, and picked up on formvar-coated copper grids. Grids
with sections were stained with uranyl acetate and lead citrate, viewed using a Tecnai-12 (FEI)
transmission electron microscope and photographed using a Zeiss 215 side mount digital cam-
era. Images were generated using AMT image capture software. Adobe Photoshop was then
used to process individual images and Illustrator was used to compile the images into panels.
The TEM images shown represent magnifications of 11,000X (panels a, b, d and e) and insets
were magnified at 30,000X (panels c and d), respectively.
Reverse transcription and real-time quantitative PCR and ELISA
To detect SVG-A cytokine transcripts, cell monolayers were washed twice with PBS following
bacterial incubation, and then RPMI 1640 plus 10% FBS was added. SVG-A cells were grown
in 24-well plates coated with collagen to confluence, and GBS was subsequently added at MOI
50 bacteria per cell (50:1) to monolayers as described above and incubated at 37°C in 5% CO2
for 2,4,6,8, and 12 hours. After infection for the indicated times, cells were rinsed with 1X PBS
and total RNA was isolated using the RNeasy miniprep kit (Qiagen Inc., Valencia, California,
USA). Total RNA was digested with DNase I to remove any contaminating genomic DNA.
Approximately 1 μg of total RNA was utilized for double-stranded cDNA synthesis using the
Superscript Choice System (Invitrogen Corp., San Diego, CA). First-strand synthesis and real-
time PCR were performed using TaqMan Universal MasterMix SYBR Green (Applied Biosys-
tems, Foster City, CA) and primer sets for IL-1β, IL-6, IL-8, and VEGF genes. The expression
level of GAPDH housekeeping gene was used as a control and fold change was reported using
the comparative Ct method. Real-time quantitative PCR (RT-qPCR) was performed using the
following primer sets (Integrated DNA Technologies, San Jose, CA): IL-6 forward primer 5'-
GGA GAC TTG CCT GGT GAA AA-3' and IL-6 reverse primer 5'-CAG GGG TGG TTA
TTG CAT CT-3'; IL-1β forward primer 5'-GAC ACA TGG GAT AAC GAG GC-3' and IL-1β
reverse primer 5'-ACG CAG GAC AGG TAC AGA TT-3'; IL-8 forward primer 5'- AGC TCT
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GTG TGA AGG TGC AG -3' and IL-8 reverse primer 5'- AAT TTC TGT GTT GGC GCA GT
-3’; VEGF forward primer 5'-ATC TGC ATG GTG ATG TTG GA-3' and VEGF reverse primer
5'-GGG CAG AAT CAT CAG GAA GT-3'; GAPDH forward primer 5'-GAA GGT GAA GGT
CGG AGT CAA CG-3' and GAPDH reverse primer 5'-TCC TGG AAG ATG GTG ATG
GAA-3’.
For ELISA SVG-A cells were grown in 12-well plates to confluence, and GBS was subse-
quently added at a MOI 50 bacteria per cell (50:1) to monolayers and incubated at 37°C in 5%
CO2. Following incubation at indicated time points, cells were washed three times with 1X PBS
and collected by addition of 100μL RIPA protein extraction buffer and scratching with a pipette
tip for 30 seconds. The concentration of IL-8 was determined in cell lysates using the human
CXCL8/IL-8 Quantikine ELISA kit (R&D Systems, Minneapolis, MN) according to manufac-
turer's instructions.
Statistical analysis
GraphPad Prism version 6 was used for statistical analysis (GraphPad Software, Inc., La Jolla,
CA). Differences between different groups were evaluated using ANOVA with Dunnett’s,
Tukey’s or Bonferroni’s multiple comparisons post-test or Unpaired, two tailed t test as indi-
cated. Statistical significance was accepted at P<0.05.
Results and Discussion
GBS Adheres to and Invades Human Astrocytes
Given that adhesion of GBS to host cells is required for invasion and overt infection, we exam-
ined the specific conditions of GBS interactions with human astrocytes utilizing the SVG-A
cell line. We observed that the SVG-A cells line, which is of human astroglial cell origin [30],
exhibited homogeneous morphology and robust expression of GFAP and CD44 as expected
(data not shown). To determine the extent of GBS surface-adherence and invasion, confluent
SVG-A cells were infected with increasing MOIs of WT GBS COH1, the hypervirulent serotype
III and sequence type (ST)-17 strain that is strongly associated with neonatal meningitis [31].
The amount of surface adherent and invasive GBS increased with increasing MOI (Fig 1A).
The percentage of adherent and intracellular bacteria ranged from 0.01%–4.2% for total cell as-
sociated GBS and from 0%–2.1% for invasion compared with the original inoculum (Fig 1A)
At the standard inoculum used (MOI 1–10), approximately 50% of total SVG-A-associated
GBS had invaded the intracellular compartment within the 2 h incubation period, suggesting
efficient uptake of surface-adherent organisms. The weakly hemolytic COH1 strain did not ap-
pear to be cytotoxic even at MOI of 10, as SVG-A monolayers remained intact as assessed by
trypan blue exclusion staining (Fig 1B). A key event leading to bacterial internalization of host
cells involves actin polymerization. To examine if this host cellular process is important for
GBS invasion of human astrocytes, SVG-A cells were treated with cytochalasin D to inhibit
actin polymerization. Confluent monolayers of SVG-A cells were treated with varying concen-
trations of cytochalasin D or DMSO vehicle control for 30 mins at 37°C with 5% CO2. After cy-
tochalasin D pretreatment, SVG–A cells were then infected with GBS COH1 strain at an MOI
of 1 for 2 h. Monolayers were then washed and processed to determine the amount of internal-
ized bacteria as described in Materials and Methods. GBS invasion was similar in non-treated
or DMSO-treated controls (data not shown). We observed a decrease in GBS invasion in astro-
cytic cells in the presence of cytochalasin D compared to the DMSO treated control (Fig 1C).
These results suggest that GBS requires actin polymerization and cytoskeletal rearrangement of
the host cell for uptake into astrocytes. This finding is consistent with previous reports
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demonstrating the requirement of actin polymerization and cytoskeletal rearrangement for the
uptake of bacteria into host cells [32]-[33],[3].
GBS invasion of human astrocytes was confirmed and visualized using transmission elec-
tron microscopy (TEM). SVG-A cells were either mock infected or infected with WT GBS
COH1 at an MOI of 10 for 2 h at 37°C and 5% CO2. Cells were then treated with antibiotics for
2 or 4 h to remove extracellular bacteria and then processed for TEM. GBS was observed within
Fig 1. Interaction of GBS with human SVG-A astrocytes. A, confluent monolayers of SVG-A cells were infected with GBS strain COH1 at the indicated
MOI for 30 minutes for adhesion and 2 h for invasion assays and the extent of bacterial adherence and invasion were quantified as described in Materials and
Methods. The data are expressed as the percentage of recovered CFU/initial inoculum. All experiments were performed in triplicate and repeated in at least
three independent experiments. B, SVG-A cells were infected with COH1 at an MOI of 1 and 10 for 24 hours and percent cell viability determined by trypan
blue dye exclusion and compared to an uninfected control. C, SVG-A cells were pretreated in media alone, DMSO vehicle control or cytochalasin D (Cyt D) at
1 to 5 μg/ml for 30 min at 37°C and 5%CO2. Cells were then incubated with COH1 at an MOI of 1 for 2 h and intracellular GBS was quantified. The data
shown represents the percentage of bacterial uptake after cytochalasin D treatment relative to untreated control. Significance was determined by one-way
ANOVA using tukeys multiple comparison test, P < 0.0001 (****). D, Transmission electron microscopic (TEM) images of SVG-A cells that were either
uninfected (control) or infected with GBS COH1 at an MOI of 10. For TEM scale bars for panels A, B, D, and E are 2um and for C and F are 500nm.
doi:10.1371/journal.pone.0128431.g001
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membrane bound intracellular vesicles within astrocytes, and under these conditions the
SVG-A morphology was not affected by GBS infection (Fig 1D). Together these data confirm
previous reports and demonstrate that GBS has the capacity to adhere to and invade human as-
trocytes. Interestingly, after 4 h of antibiotic treatment we observed an increase in the number
of vesicles containing intracellular GBS present in SGV-A compared to the 2 h time point (Fig
1D, panels b, c, e and f). In addition, several bacteria appear to have septa that are indicative of
bacterial division and vesicular-like structures appear to be fusing (Fig 1D, panels c and f).
Autophagosomes are frequently observed fusing with endosomal or lysosomal vesicles and are
double membrane structures [34]. Reports show that in TEM plastic sections, the double mem-
branes can be so close to each other that it is not possible to see them as separate membranes
and sometimes the autophagosome limiting membrane does not have any contrast in thin sec-
tions [35]. Although, the internal vesicles containing GBS may be reminiscent of autophago-
somes [36–38], we have not yet defined the nature of these compartments.
Analysis of GBS—Astrocyte Interaction
Next, we evaluated the extent of GBS wild-type COH1 adherence to and invasion of SVG-A
cells over time. SVG-A cells grown to confluence were incubated with COH1 at an MOI of
1 for 0 to 90 min at 37°C and 5% CO2 and total cell associated GBS was examined. Interesting-
ly, the extent of GBS adherence to SVG-A cells did not significantly change over the 90 min
time-course, suggesting that the levels of adherent bacteria remains quantitatively consistent
over this time course (Fig 2A). In contrast, invasion of SVG-A cells by COH1 at an MOI of 1
markedly increased from 4 to 6 h post infection and appears to reach steady-state following 8 h
post infection (Fig 2B). These results suggest that SVG-A cells are susceptible to invasion for
many hours and this results in a substantial amount of GBS accumulation that appears to be
maximal at 6 and 8 h post infection (Fig 2B). We further used fluorescence microscopy to visu-
alize a COH1-GFP persisting inside SVG-A cells at 8 h as described in Materials and Methods
(Fig 2C).
Next, we examined whether human astrocytes were susceptible to invasion by other clinical-
ly relevant GBS isolates representing diverse serotypes as described in Table 1. The GBS capsu-
lar serotypes commonly associated with bloodstream infections in newborns are Ia, Ib, II, III,
and V, with type III accounting for a disproportionate amount of meningeal infection [3, 39].
We compared invasion of SVG-A cells by two clinically dominant GBS clinical isolates, COH1
and NCTC 10/84 (serotype III and V respectively) to the clinical isolates belonging to other
capsular serotypes which include strains 515 (Ia), H36B (Ib), A909 (Ia) and NEM316 (III). Our
data indicate that all GBS strains exhibited varying levels of adherence and invasion compared
to COH1 (Fig 3A and 3B). Interestingly the hyper-hemolytic strain NCTC 10/84 was equally
adherent and invasive as COH1, suggesting that toxin production may not impact these inter-
actions. In contrast, GBS strains 515, H36B, and NEM316 exhibited minimal adherence and/or
invasion of SVG-A cells compared to COH1 (Fig 3A and 3B). These findings demonstrate that
GBS isolates are able to adhere and invade astrocytes to varying degrees, which may be due to
differences in cell surface expressed determinants resulting in divergent affinities or capacities
for binding to human astrocytes. The variable invasiveness exhibited by the different GBS
strains has been previously observed for other cell types such as human vaginal epithelial cells
[40], human pulmonary alveolar epithelial cells (A549)[41], human umbilical vein endothelial
cells (HUVEC)[42], and human brain endothelial cells (hBMEC) [3, 43]. Interestingly, there
was no correlation between the ability of GBS to adhere versus invade astrocytic cells (Fig 3A
and 3B).
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Fig 2. GBS adhesion, invasion and intracellular survival of SVG-A cells. A and B, Confluent monolayers of SVG-A cells were incubated with GBS,
COH1 wild-type strain, at an MOI of 1 for various times at 37°C, 5% CO2 and adhesion and invasion was examined as described in Materials and Methods.
The data shown are a representative of 3 independent experiments performed in triplicate. Incubation at shorter and longer times resulted in a similar level of
adhesion and invasion of COH1 to SVG-A cells and was not statistically significant as determined by one-way ANOVA and Tukey's multiple comparison
tests. C, SVG-A cells were infected with COH1 expressing GFP at an MOI of 10 and incubated for 8 h at 37°C. Cells were fixed and processed for
fluorescence microscopy and stained with Cell Mask (red) to visualize the plasmamembrane or with DAPI (blue) to visualize the nucleus. The image is
representative of many images from 2 independent experiments.
doi:10.1371/journal.pone.0128431.g002
Table 1. Bacterial strains used in the study.
Organism ATCC Reference No. Serotype Comments Reference
S. agalactiae
COH1 BAA 1176 III WT, highly encapsulated [77]
HY106 —— III COH1, capsule mutant [9, 28]
COH1ΔcylE —— III ß-h/c deficient [27, 41]
COH1ΔiagA III Lack LTA anchor [10, 78]
COH1ΔsfbA III SfbA deficient [14]
NCTC 10/84 ATCC: 49447; 1169-NT1 V WT, hyper hemolytic [79]
NCTC 10/84 ΔcylE —— V ß-h/c deficient [27]
NCTC 10/84 ΔpilA —— V Lacks pilus tip adhesin [18]
NCTC 10/84 ΔpilB —— V Lacks pilus backbone [18, 78]
NCTC 10/84 Δsrr-1 V Lacks Serine Rich Repeat Protein [12]
A909 BAA : 1138 Ia WT [80]
515 —— Ia WT [81],[82]
H36B BAA : 1174 Ib WT [81]
NEM 316 ATCC: 12403 III WT [82]
S. gordonii M99 —— Type 37 capsule polysaccharide WT [83, 84]
WT, wild-type
doi:10.1371/journal.pone.0128431.t001
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We next assessed whether astrocyte adherence and invasion was specific by examining an-
other streptococcal species, Streptococcus gordonii, a Gram-positive oral pathogen. Our results
demonstrated that S. gordonii, exhibited similar levels of attachment to SVG-A cells compared
to COH1, but was not able to invade these cells (Fig 3C). Together these data suggest that there
may be unique factors expressed by GBS that facilitate adherence and invasion that are essen-
tial to trigger bacterial entry into astrocytes.
Contribution of GBS virulence factors to astrocyte interactions
The interaction of bacterial surface components with host cell receptors to initiate cell and tis-
sue penetration is a prerequisite for development of severe invasive disease. GBS surface ex-
pressed factors shown to promote GBS attachment and/or invasion of different host cell types
include the invasion associated gene, iagA [10], capsule [9, 28], β-hemolysin/cytolysin (β-h/c)
[9], pili [18], serine-rich repeat glycoproteins, including Srr-1 [12], fibrinogen-binding proteins
[44, 45], and a recently identified fibronectin binding protein, SfbA [14]. To investigate the im-
portance of certain bacterial components in the adherence and invasion of human astrocytes,
wild-type GBS and isogenic mutants were used (see Table 1). Confluent monolayers of SVG-A
cells were infected with an MOI of 1 of wild type COH1 and NCTC10/84 strains and indicated
isogenic mutants. The ΔiagAmutant exhibited reduced levels of adherence and invasion com-
pared to the parental COH1 strain (Fig 4A and 4B). The iagA gene encodes a glycosyltransfer-
ase that is required for the synthesis of glycolipid diglucosyldiacylglycerol, a cell membrane
anchor for lipoteichoic acid (LTA) [10]. Previous studies have shown that iagA function is im-
portant to properly anchor LTA in the GBS cell wall, and that LTA expression on the GBS sur-
face plays a role in bacterial interaction with BBB endothelium and the pathogenesis of
neonatal meningitis [10]. Thus our data suggest that similar interactions are important for
GBS attachment and entry into astrocytic cells. Our results also demonstrate that fibronectin
binding protein, SfbA, is important for invasion into astrocytes, although it did not contribute
to GBS attachment (Fig 4A and 4B). These results are similar to that observed for the role of
SfbA in the interaction of GBS with host endothelial and epithelial cells [14]. In contrast, the
unencapsulated HY106 strain displayed an increase in both adherence and invasion (Fig 4A
and 4B). This is not completely unexpected as the polysaccharide capsule likely masks bacterial
surface determinants that may promote interaction with the host cell.
Fig 3. Clinically relevant isolates of GBS adhere and invade, but non-GBS, bacteria fail to invade human astrocytes. A and B, Wild-type GBS
serotypes (Ia, Ib, III, and V), were incubated with confluent SVG-A cells at an MOI of 1 for 30 minutes for adhesion and 2 h for invasion assays and the levels
of both surface-adherence and invasion were quantified. These data are expressed as the relative percentage of clinical isolates compared to COH1, a
representative experiment of at least 3 independent experiments performed in triplicate is shown. C, SVG-A cells grown to confluence were infected with
GBS COH1 at an MOI of 1 or the non-GBS strain, S. gordonii for 30 min for adhesion or 2 h for invasion assays. An unpaired, two tailed t-test with Welch’s
correction was used to compare S. gordonii to COH1. Data are expressed as the relative percent adherence or invasion and are representative of 3
independent experiments performed in triplicate or quadruplicate.
doi:10.1371/journal.pone.0128431.g003
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Interestingly, isogenic mutants in both strain backgrounds that were deficient in β-h/c
(ΔcylE) exhibited similar levels of adherence and invasion to parental strains (Fig 4). This sug-
gests that toxin production does not contribute to cellular interactions and is consistent with
our results above comparing the interactions of COH1 (weakly hemolytic) to NCTC 10/84
(hyper-hemolytic). Additionally, previous studies also demonstrated that toxin production did
not impact GBS adherence to astrocytic cells [25].
Proteins targeted for cell surface expression in GBS are predicted to share a C-terminal se-
quence (L/IPXTG) for sortase recognition and anchoring to the Gram-positive cell wall. Several
cell wall anchored proteins promoting GBS interaction with brain microvascular endothelial
cells have been identified and characterized [23]. An important determinant recently implicat-
ed in fibrinogen binding and BBB interaction are the GBS serine rich repeat (Srr) glycoproteins
[12] Srr proteins have a highly conserved domain organization, including a long and special-
ized signal sequence, two extensive serine-rich repeat regions that undergo glycosylation, and a
typical LP(X)TG cell wall anchoring motif. We observed that Srr-1 contributed significantly to
astrocyte entry, even though the Srr-1 deficient mutant appeared to be more adherent (Fig 4C
and 4D). These results are similar to what has been reported previously in BBB endothelium
[12], demonstrating that GBS Srr-1 contributes to penetration of different host cell barriers.
Additional cell wall anchored proteins in GBS make up pilus structures. Pili are flexible ap-
pendages on the bacterial surface that mediate infection, including adhesion to host cells, DNA
transfer and biofilm formation [46–48]. Cell surface pili have been described in GBS and other
Fig 4. Role of GBS surface determinants in SVG-A interaction. A and B, SVG-A cells grown to confluence were infected at an MOI of 1 with wild type
strains COH1 or NCTC10/84 and respective isogenic mutants. SVG-A cells were infected for 30 min for adhesion or 2 h for invasion assays, bacteria were
recovered and quantified as described in Materials and Methods. A representative experiment of at least 3 independent experiments performed in triplicate is
shown. Data are expressed as the percentage of recovered CFU for GBSmutants relative to that of the wild type parental strain. Data were analyzed by
unpaired, two-tailed t-test. (*) = P< 0.05, (**), P< 0.01 and (****), P< 0.0001.
doi:10.1371/journal.pone.0128431.g004
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streptococcal pathogens [49–51]. The genes encoding pili in GBS are located within two dis-
tinct loci, and generally consist of three genes that encode LPXTG motif-carrying proteins cor-
responding to the major pilus subunit (PilB), two ancillary proteins (PilA and PilC; [52]). We
examined the ability of isogenic mutants lacking either PilA or PilB to interact with the SVG-A
cell line. Surprisingly we did not observe a difference in the ability of PilA or PilB deficient mu-
tants to interact with astrocytes compared to the WT parental strain (Fig 4C and 4D). Thus,
SVG-A cells may also recognize GBS independent of typical bacterial attachment mechanisms.
One of the functional roles of astrocytes is to clean up cell debris in order to limit tissue damage
following injury or infection of the brain [53, 54]. Astrocytes possess MEGF10 (multiple EGF-
like-domains 10) and P2X7 receptors, which are known to be phagocytic receptors [54, 55]. Al-
ternatively, astrocytes have been reported to become activated and proliferate when exposed to
bacterial endotoxins and lipopolysaccharides (LPS)[56–58]. It is possible that GBS is recog-
nized and enters astrocytic cells by phagocytosis, but future studies are needed to examine
this possibility.
GBS Intracellular Survival in Human Astrocytes
We sought to determine if GBS may survive intracellularly and replicate within astrocytes for
longer periods of time following intracellular invasion. To test this, we recovered intracellular
GBS following antibiotic treatment to kill extracellular bacteria over time as described in Mate-
rials and Methods. We observed that GBS was able to survive for up to 12 h post infection re-
gardless of the initial MOI used (Fig 5A). GBS infected cells were also examined by TEM over a
2 to 12 h time-course (5B). This was done to assess cell morphology after infection over time
and to confirm our findings. Intriguingly, dividing forms of GBS COH1 were observed inside
SVG-A cells within large endocytic vacuoles after 2 h post infection (Fig 5B, panels f-o). In ad-
dition, the number of intracellular GBS COH1 detected increased considerably from 6 h to 12
h (Fig 5B, panels f-o). We were also able to capture images of bacteria with septa, which are in-
dicative of dividing bacteria [59, 60], along with electron dense material around or between
these bacteria (Fig 5B, panels h-o). This electron dense material was only observed at the later
times and may be evidence of a bacterial protein or biofilm being secreted. Some of internal
compartments also contained an increase of number of bacteria or bacterial aggregates (Fig 5B,
panels g-o), whereas other internal compartments containing bacteria appear to be fused to-
gether (Fig 5B, panels h-j and m-o). These data indicated that GBS persists within SVG-A cells
for an extended period of time following invasion and possibly undergo replication and fusion
within intracellular compartments. However our recovery and quantification of viable cfu (Fig
5A) suggests that there is no net replication over time.
Astrocyte activation during GBS infection
Proinflammatory cytokines IL-1β and IL-6 are major early response mediators that often trig-
ger other cytokines and chemokines, arachidonic acid metabolites, and reactive nitrogen and
oxygen intermediates in response to tissue injure or infection [61–63]. Multiple cell types with-
in the CNS including microvascular endothelial cells, astrocytes, and microglia secrete IL-1β,
and IL-6. Increased concentrations of these cytokines have been detected in cerebral spinal flu-
ids taken from patients with acute bacterial meningitis and concentrations of IL-1β are associ-
ated with significantly an increase in disease severity [64].
Alterations in synthesis and release of cytokines as a host response to GBS infections have
previously been shown to weaken barrier integrity (mucosal, epithelial, endothelial) by the
upregulation of interleukins 1, 6, 8 (IL-1β, IL-6, IL-8)—[9, 15, 65–69]. We first examined the
cytokine production of GBS infected astrocytes. The measurement of pro-inflammatory
Group B Streptococcal Infection and Activation of Human Astrocytes
PLOS ONE | DOI:10.1371/journal.pone.0128431 June 1, 2015 11 / 18
cytokines IL-1β, IL-6, chemokine IL-8, and vascular endothelial growth factor (VEGF) signal-
ing protein was carried out by quantifying mRNA expression levels as described previously
Fig 5. Intracellular survival of wild-type GBS in human astrocytes. A, Wild-type GBS, COH1, intracellular survival assays in SVG-A cells were carried out
for up to 12 hr at MOI of 1 and 10. To assess intracellular survival in SVG-A cells over time, intracellular bacteria were enumerated after the addition of
antibiotics (gentamicin (50 μg/ml) and penicillin (25 μg/ml) from 2 to 12 h time points. B, Transmission electron micrographs demonstrating GBS (COH1)
intracellular survival over time in SVG-A cells at magnifications (6,000X for A-J, and 30,000X for K-O). All assays were performed in triplicate or quadruplet
and repeated at least three times.
doi:10.1371/journal.pone.0128431.g005
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[15]. We investigated these factors due to their role in the host response during GBS infection
of brain endothelium and other cell types [9, 66, 67, 70–72]. SVG-A cells were infected with
GBS over time as described in Materials and Methods and transcript abundance of IL-1β, IL-6,
IL-8 and VEGF were measured and normalized to the expression level of GAPDH housekeep-
ing gene and compared to uninfected controls. All cytokines were significantly induced during
GBS infection at all time points examined (Fig 6A–6D). An ELISA was performed to assay IL-8
protein levels, which demonstrated a significant increase in IL-8 protein at 4 hours post GBS
infection (Fig 6E). These results are the first to demonstrate that GBS infection induces astro-
cyte cytokine production, which may contribute to the increase in meningeal inflammation.
We hypothesize that once the GBS penetrates brain endothelial cells and gains access to astro-
cytes, GBS further induces an astrocytic inflammatory response, which could impact endotheli-
al barrier integrity. IL-8 is a potent neutrophil chemokine that is involved in neutrophil
activation and recruitment [73] neutrophil migration has been shown to promote BBB perme-
ability during experimental GBS meningitis [15]. Secretion of cytokines and chemokines by as-
trocytes may allow GBS to penetrate further through the BBB, thus, contributing to the
progression of meningitis. Alternatively, this immune response may represent an effective sec-
ond line of host defense or neuroprotection [74, 75], preventing further penetration of GBS
into the CNS. However, subsequent increases in proinflammatory pathways produced after
GBS infection, could intensify the permeability or leakiness of the BBB resulting in further ex-
acerbation or the development of meningitis. Interestingly VEGF, which increases brain endo-
thelial permeability when given intravenously, is neuroprotective and reduces BBB leakage
after ischemia when given intraventricularly [76]. Further investigation is required to deter-
mine the exact role of astrocyte derived VEGF and other proinflammatory cytokines on BBB
permeability during GBS meningitis.
In summary we have demonstrated that GBS actively invades and persists in human astro-
cytes and that various bacterial surface factors promote these interactions. Further astrocytes
respond to GBS infection with a robust proinflammatory response, which may impact disease
Fig 6. Activation of human astrocytes following GBS infection. A-D, Transcript abundance of IL-1β, IL-6, VEGF, and IL-8 in SVG-A cells was determined
using quantitative RT-PCR following infection with GBS COH1 (MOI = 50). Fold change was calculated using GAPDH and then normalized to media controls
as described in Materials and Methods. E, Protein production of IL-8 was determined by ELISA as described in Materials and Methods. Data is one
representative experiment of at least 2 independent experiments performed in a minimum of 4 replicates. Data was analyzed by two-way ANOVA with
Bonferroni’s multiple comparisons post-test. (*) = P< 0.05, (***) = P< 0.001, (****) = P< 0.0001.
doi:10.1371/journal.pone.0128431.g006
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progression. Understanding the role of astrocytes and the NVU during bacterial infection will
provide important information regarding BBB disruption and the development of neonatal
meningitis.
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